Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-05T05:02:35.622Z Has data issue: false hasContentIssue false

16 - Role of Matrix Metalloproteinases in Tumor Invasion and Metastasis

from STROMAL CELLS/EXTRACELLULAR MATRIX

Published online by Cambridge University Press:  05 June 2012

Barbara Fingleton
Affiliation:
Vanderbilt University School of Medicine, United States
David Lyden
Affiliation:
Weill Cornell Medical College, New York
Danny R. Welch
Affiliation:
Weill Cornell Medical College, New York
Bethan Psaila
Affiliation:
Imperial College of Medicine, London
Get access

Summary

Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that act outside the cell to alter the environment. As implied by their name, molecules that constitute the extracellular matrix (ECM), which includes basement membranes as well as interstitial fibers, are substrates of the MMP enzyme family. Other substrates include growth, death, chemotactic, and other signaling factors, as well as proteinases and proteinase inhibitors. The ability to modulate this vast array of different types of proteins means that MMPs can be potent regulators of cellular behavior. In this chapter, we review the discovery and study of MMPs and describe the current thinking of how MMPs contribute to tumor progression, specifically the processes of invasion and metastasis. To properly understand biological functions of MMPs, in vitro and in vivo methods for their analysis have been developed. Using such analytical tools wisely requires an understanding of their limitations and possible interpretations. Despite an immense amount of research concerning this important group of proteases in cancer, as well as in other pathological and physiological conditions, there are still multiple unanswered questions; thus, we end this chapter by considering some of these.

DISCOVERY AND CHARACTERIZATION OF MMPS

In humans, the MMP family currently comprises twenty-three members, although inclusion of all mammalian as well as frog and avian MMPs bring the total known to twenty-five. These enzymes are most simply known as MMP-1 to MMP-28.

Type
Chapter
Information
Cancer Metastasis
Biologic Basis and Therapeutics
, pp. 183 - 190
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Woessner, JF, Nagase, H (2000) Matrix Metalloproteinases and TIMPs. Oxford, UK: Oxford University Press.Google Scholar
Gross, J, Lapiere, CM (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA. 48: 1014.CrossRefGoogle ScholarPubMed
Brinckerhoff, CE, Matrisian, LM (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 3: 207.CrossRefGoogle ScholarPubMed
Carmichael, DF, Sommer, A et al. (1986) Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA. 83: 2407.CrossRefGoogle ScholarPubMed
Cruz-Munoz, W, Khokha, R (2008) The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit Rev Clin Lab Sci. 45: 291.CrossRefGoogle ScholarPubMed
Matrisian, LM, Glaichenhaus, N et al. (1985) Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J. 4: 1435.Google ScholarPubMed
Goldberg, GI, Wilhelm, SM et al. (1986) Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem. 261: 6600.Google Scholar
Wart, HE, Birkedal-Hansen, H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA. 87: 5578.CrossRefGoogle ScholarPubMed
Nagase, H, Visse, R et al. (2006)Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 69: 562.CrossRefGoogle ScholarPubMed
Pei, D, Weiss, SJ (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 375: 244.CrossRefGoogle ScholarPubMed
Rabbani, SA, Mazar, AP (2001) The role of the plasminogen activation system in angiogenesis and metastasis. Surg Oncol Clin North Am. 10: 393.Google ScholarPubMed
Shapiro, SD (1997) Mighty mice: transgenic technology “knocks out” questions of matrix metalloproteinase function. Matrix Biol. 15: 527.CrossRefGoogle ScholarPubMed
Holmbeck, K, Bianco, P et al. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99: 81.CrossRefGoogle ScholarPubMed
Zhou, Z, Apte, SS et al. (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane type matrix metalloproteinase I. Proc Natl Acad Sci USA. 97: 4052.CrossRefGoogle ScholarPubMed
Rudolph-Owen, , Hulboy, DL et al. (1997) Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology. 138: 4902.CrossRefGoogle ScholarPubMed
Seals, DF, Courtneidge, SA (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17: 7.CrossRefGoogle ScholarPubMed
Hurskainen, TL, Hirohata, S et al. (1999) ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family. J Biol Chem. 274: 25555.CrossRef
Liotta, , Tryggvason, K et al. (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284: 67.CrossRefGoogle ScholarPubMed
Khokha, R, Waterhouse, P et al. (1989) Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science. 243: 947.CrossRefGoogle ScholarPubMed
Kim, J, Yu, W et al. (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell. 94: 353.CrossRef
Koop, S, Khokha, R et al. (1994) Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res. 54: 4791.Google Scholar
Sabeh, F, Ota, I et al. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol. 167: 769.CrossRefGoogle ScholarPubMed
Egeblad, M, Werb, Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nature Rev Cancer. 2: 161.CrossRefGoogle ScholarPubMed
Yu, Q, Stamenkovic, I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14: 163.Google ScholarPubMed
Martin, MD, Matrisian, LM (2007) The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev. 26: 717.CrossRefGoogle ScholarPubMed
Cornelius, , Nehring, LC et al. (1998) Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol. 161: 6845.Google ScholarPubMed
Bergers, G, Brekken, R et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol. 2: 737.CrossRefGoogle ScholarPubMed
Lee, S, Jilani, SM et al. (2005)Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol. 169: 681.CrossRefGoogle ScholarPubMed
Bix, G, Iozzo, RV (2005) Matrix revolutions: “tails” of basement-membrane components with angiostatic functions. Trends Cell Biol. 15: 52.CrossRefGoogle ScholarPubMed
Funovics, M, Weissleder, R et al. (2003) Protease sensors for bioimaging. Anal Bioanal Chem. 377: 956.CrossRefGoogle ScholarPubMed
Brown, PD (1999) Clinical studies with matrix metalloproteinase inhibitors. APMIS. 107: 174.CrossRefGoogle ScholarPubMed
Coussens, LM, Fingleton, B et al. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 295: 2387.CrossRef
Beattie, GJ, Smyth, JF (1998) Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. Clin Cancer Res. 4: 1899.Google ScholarPubMed
Fingleton, B (2003) Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects. Expert Opin Ther Targets. 7: 385.CrossRefGoogle ScholarPubMed
Bergers, G, Javaherian, K et al. (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284: 808.CrossRefGoogle ScholarPubMed
Lopez-Otin, C, Overall, CM (2002) Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol. 3: 509.CrossRefGoogle ScholarPubMed
Overall, CM, Tam, EM et al. (2004) Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol Chem. 385: 493.CrossRefGoogle ScholarPubMed
Kaplan, RN, Riba, RD et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 438: 820.CrossRef
Hiratsuka, S, Nakamura, K et al. (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell. 2: 289.CrossRefGoogle ScholarPubMed
Acuff, HB, Carter, KJ et al. (2006) Matrix metal-loproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res. 66: 259.CrossRefGoogle Scholar
Martin, MD, Carter, KJ et al. (2008) Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res. 68: 6251.CrossRef
Wolf, K, Mazo, I et al. (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 160: 267.CrossRef

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×